Paclitaxel- Versus Sirolimus-Eluting Stents for Unprotected Left Main Coronary Artery Disease
- 5 May 2009
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 53 (19), 1760-1768
- https://doi.org/10.1016/j.jacc.2009.01.035
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Stents or Surgery?Circulation, 2008
- Left main coronary artery stenosis no longer a risk factor for early and late death after coronary artery bypass surgery — an experience covering three decadesEuropean Journal of Cardio-Thoracic Surgery, 2006
- Validation of Predictors of Intraprocedural Stent Thrombosis in the Drug-Eluting Stent EraThe American Journal of Cardiology, 2005
- Multivessel Off-Pump Revascularization in Patients with Significant Left Main Coronary Artery Stenosis:. Early and Midterm Outcome AnalysisJournal of Cardiac Surgery, 2005
- Early and Mid-Term Results of Drug-Eluting Stent Implantation in Unprotected Left MainCell Metabolism, 2005
- Relationship of Late Loss in Lumen Diameter to Coronary Restenosis in Sirolimus-Eluting StentsCirculation, 2005
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Logistic or additive EuroSCORE for high-risk patients?☆European Journal of Cardio-Thoracic Surgery, 2003
- Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists CollaborationThe Lancet, 1994
- Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease.Cell Metabolism, 1982